Market Research Logo

Human Microbiome - Global Market Outlook (2016-2022)

1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 Product Analysis
3.8 Research Scenario
3.9 Emerging Markets
3.10 Supply Chain Analysis
3.11 Futuristic Market Scenario
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Human Microbiome Market, By Application
5.1 Introduction
5.2 Diagnostics
5.3 Therapeutics
6 Global Human Microbiome Market, By Disease
6.1 Introduction
6.2 Cancer
6.3 Acute Diarrhea
6.4 Diabetes
6.5 Mental Disorders
6.6 Autoimmune Disorders
6.7 Obesity
6.8 Other Diseases
7 Global Human Microbiome Market, By Product
7.1 Introduction
7.2 Foods
7.3 Drugs
7.4 Probiotics
7.5 Diagnostic Devices
7.6 Prebiotics
7.7 Medical Foods
7.7.1 Nutritionally Incomplete Formulae
7.7.2 Formulae for Metabolic Disorders
7.7.3 Nutritionally Complete Formulae
7.7.4 Oral Rehydration Products
7.8 Other Probiotic Supplements
8 Global Human Microbiome Market, By Geography
8.1 North America
8.1.1 US
8.1.2 Canada
8.1.3 Mexico
8.2 Europe
8.2.1 Germany
8.2.2 France
8.2.3 Italy
8.2.4 UK
8.2.5 Spain
8.2.6 Rest of Europe
8.3 Asia Pacific
8.3.1 Japan
8.3.2 China
8.3.3 India
8.3.4 Australia
8.3.5 New Zealand
8.3.6 Rest of Asia Pacific
8.4 Rest of the World
8.4.1 Middle East
8.4.2 Brazil
8.4.3 Argentina
8.4.4 South Africa
8.4.5 Egypt
9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 Company Profiling
10.1 Ritter Pharmaceuticals, Inc.
10.2 E. I. du Pont de Nemours and Company
10.3 ViThera Pharmaceuticals
10.4 Metabiomics Corp.
10.5 ActoGeniX
10.6 Optibiotix Health Plc
10.7 Vedanta Biosciences, Inc.
10.8 MicroBiome Therapeutics, LLC
10.9 Second Genome, Inc.
10.10 ENTEROME Bioscience
10.11 Yakult Honsha Co., Ltd.
10.12 Osel, Inc.
10.13 AvidBiotics
10.14 Rebiotix Inc.,
10.15 Merck & Co., Inc.
10.16 Seres Therapeutics
List of Tables
Table 1 Global Human Microbiome Market Outlook, By Region (2013-2022) ($MN)
Table 2 Global Human Microbiome Market Outlook, By Application (2013-2022) ($MN)
Table 3 Global Human Microbiome Market Outlook, By Diagnostics (2013-2022) ($MN)
Table 4 Global Human Microbiome Market Outlook, By Therapeutics (2013-2022) ($MN)
Table 5 Global Human Microbiome Market Outlook, By Disease (2013-2022) ($MN)
Table 6 Global Human Microbiome Market Outlook, By Cancer (2013-2022) ($MN)
Table 7 Global Human Microbiome Market Outlook, By Acute Diarrhea (2013-2022) ($MN)
Table 8 Global Human Microbiome Market Outlook, By Diabetes (2013-2022) ($MN)
Table 9 Global Human Microbiome Market Outlook, By Mental Disorders (2013-2022) ($MN)
Table 10 Global Human Microbiome Market Outlook, By Autoimmune Disorders (2013-2022) ($MN)
Table 11 Global Human Microbiome Market Outlook, By Obesity (2013-2022) ($MN)
Table 12 Global Human Microbiome Market Outlook, By Other Diseases (2013-2022) ($MN)
Table 13 Global Human Microbiome Market Outlook, By Product (2013-2022) ($MN)
Table 14 Global Human Microbiome Market Outlook, By Foods (2013-2022) ($MN)
Table 15 Global Human Microbiome Market Outlook, By Drugs (2013-2022) ($MN)
Table 16 Global Human Microbiome Market Outlook, By Probiotics (2013-2022) ($MN)
Table 17 Global Human Microbiome Market Outlook, By Diagnostic Devices (2013-2022) ($MN)
Table 18 Global Human Microbiome Market Outlook, By Prebiotics (2013-2022) ($MN)
Table 19 Global Human Microbiome Market Outlook, By Medical Foods (2013-2022) ($MN)
Table 20 Global Human Microbiome Market Outlook, By Nutritionally Incomplete Formulae (2013-2022) ($MN)
Table 21 Global Human Microbiome Market Outlook, By Formulae for Metabolic Disorders (2013-2022) ($MN)
Table 22 Global Human Microbiome Market Outlook, By Nutritionally Complete Formulae (2013-2022) ($MN)
Table 23 Global Human Microbiome Market Outlook, By Oral Rehydration Products (2013-2022) ($MN)
Table 24 Global Human Microbiome Market Outlook, By Other Probiotic Supplements (2013-2022) ($MN)
Table 25 North America Human Microbiome Market Outlook, By Country (2013-2022) ($MN)
Table 26 North America Human Microbiome Market Outlook, By Application (2013-2022) ($MN)
Table 27 North America Human Microbiome Market Outlook, By Diagnostics (2013-2022) ($MN)
Table 28 North America Human Microbiome Market Outlook, By Therapeutics (2013-2022) ($MN)
Table 29 North America Human Microbiome Market Outlook, By Disease (2013-2022) ($MN)
Table 30 North America Human Microbiome Market Outlook, By Cancer (2013-2022) ($MN)
Table 31 North America Human Microbiome Market Outlook, By Acute Diarrhea (2013-2022) ($MN)
Table 32 North America Human Microbiome Market Outlook, By Diabetes (2013-2022) ($MN)
Table 33 North America Human Microbiome Market Outlook, By Mental Disorders (2013-2022) ($MN)
Table 34 North America Human Microbiome Market Outlook, By Autoimmune Disorders (2013-2022) ($MN)
Table 35 North America Human Microbiome Market Outlook, By Obesity (2013-2022) ($MN)
Table 36 North America Human Microbiome Market Outlook, By Other Diseases (2013-2022) ($MN)
Table 37 North America Human Microbiome Market Outlook, By Product (2013-2022) ($MN)
Table 38 North America Human Microbiome Market Outlook, By Foods (2013-2022) ($MN)
Table 39 North America Human Microbiome Market Outlook, By Drugs (2013-2022) ($MN)
Table 40 North America Human Microbiome Market Outlook, By Probiotics (2013-2022) ($MN)
Table 41 North America Human Microbiome Market Outlook, By Diagnostic Devices (2013-2022) ($MN)
Table 42 North America Human Microbiome Market Outlook, By Prebiotics (2013-2022) ($MN)
Table 43 North America Human Microbiome Market Outlook, By Medical Foods (2013-2022) ($MN)
Table 44 North America Human Microbiome Market Outlook, By Nutritionally Incomplete Formulae (2013-2022) ($MN)
Table 45 North America Human Microbiome Market Outlook, By Formulae for Metabolic Disorders (2013-2022) ($MN)
Table 46 North America Human Microbiome Market Outlook, By Nutritionally Complete Formulae (2013-2022) ($MN)
Table 47 North America Human Microbiome Market Outlook, By Oral Rehydration Products (2013-2022) ($MN)
Table 48 North America Human Microbiome Market Outlook, By Other Probiotic Supplements (2013-2022) ($MN)
Table 49 Europe Human Microbiome Market Outlook, By Country (2013-2022) ($MN)
Table 50 Europe Human Microbiome Market Outlook, By Application (2013-2022) ($MN)
Table 51 Europe Human Microbiome Market Outlook, By Diagnostics (2013-2022) ($MN)
Table 52 Europe Human Microbiome Market Outlook, By Therapeutics (2013-2022) ($MN)
Table 53 Europe Human Microbiome Market Outlook, By Disease (2013-2022) ($MN)
Table 54 Europe Human Microbiome Market Outlook, By Cancer (2013-2022) ($MN)
Table 55 Europe Human Microbiome Market Outlook, By Acute Diarrhea (2013-2022) ($MN)
Table 56 Europe Human Microbiome Market Outlook, By Diabetes (2013-2022) ($MN)
Table 57 Europe Human Microbiome Market Outlook, By Mental Disorders (2013-2022) ($MN)
Table 58 Europe Human Microbiome Market Outlook, By Autoimmune Disorders (2013-2022) ($MN)
Table 59 Europe Human Microbiome Market Outlook, By Obesity (2013-2022) ($MN)
Table 60 Europe Human Microbiome Market Outlook, By Other Diseases (2013-2022) ($MN)
Table 61 Europe Human Microbiome Market Outlook, By Product (2013-2022) ($MN)
Table 62 Europe Human Microbiome Market Outlook, By Foods (2013-2022) ($MN)
Table 63 Europe Human Microbiome Market Outlook, By Drugs (2013-2022) ($MN)
Table 64 Europe Human Microbiome Market Outlook, By Probiotics (2013-2022) ($MN)
Table 65 Europe Human Microbiome Market Outlook, By Diagnostic Devices (2013-2022) ($MN)
Table 66 Europe Human Microbiome Market Outlook, By Prebiotics (2013-2022) ($MN)
Table 67 Europe Human Microbiome Market Outlook, By Medical Foods (2013-2022) ($MN)
Table 68 Europe Human Microbiome Market Outlook, By Nutritionally Incomplete Formulae (2013-2022) ($MN)
Table 69 Europe Human Microbiome Market Outlook, By Formulae for Metabolic Disorders (2013-2022) ($MN)
Table 70 Europe Human Microbiome Market Outlook, By Nutritionally Complete Formulae (2013-2022) ($MN)
Table 71 Europe Human Microbiome Market Outlook, By Oral Rehydration Products (2013-2022) ($MN)
Table 72 Europe Human Microbiome Market Outlook, By Other Probiotic Supplements (2013-2022) ($MN)
Table 73 Asia Pacific Human Microbiome Market Outlook, By Country (2013-2022) ($MN)
Table 74 Asia Pacific Human Microbiome Market Outlook, By Application (2013-2022) ($MN)
Table 75 Asia Pacific Human Microbiome Market Outlook, By Diagnostics (2013-2022) ($MN)
Table 76 Asia Pacific Human Microbiome Market Outlook, By Therapeutics (2013-2022) ($MN)
Table 77 Asia Pacific Human Microbiome Market Outlook, By Disease (2013-2022) ($MN)
Table 78 Asia Pacific Human Microbiome Market Outlook, By Cancer (2013-2022) ($MN)
Table 79 Asia Pacific Human Microbiome Market Outlook, By Acute Diarrhea (2013-2022) ($MN)
Table 80 Asia Pacific Human Microbiome Market Outlook, By Diabetes (2013-2022) ($MN)
Table 81 Asia Pacific Human Microbiome Market Outlook, By Mental Disorders (2013-2022) ($MN)
Table 82 Asia Pacific Human Microbiome Market Outlook, By Autoimmune Disorders (2013-2022) ($MN)
Table 83 Asia Pacific Human Microbiome Market Outlook, By Obesity (2013-2022) ($MN)
Table 84 Asia Pacific Human Microbiome Market Outlook, By Other Diseases (2013-2022) ($MN)
Table 85 Asia Pacific Human Microbiome Market Outlook, By Product (2013-2022) ($MN)
Table 86 Asia Pacific Human Microbiome Market Outlook, By Foods (2013-2022) ($MN)
Table 87 Asia Pacific Human Microbiome Market Outlook, By Drugs (2013-2022) ($MN)
Table 88 Asia Pacific Human Microbiome Market Outlook, By Probiotics (2013-2022) ($MN)
Table 89 Asia Pacific Human Microbiome Market Outlook, By Diagnostic Devices (2013-2022) ($MN)
Table 90 Asia Pacific Human Microbiome Market Outlook, By Prebiotics (2013-2022) ($MN)
Table 91 Asia Pacific Human Microbiome Market Outlook, By Medical Foods (2013-2022) ($MN)
Table 92 Asia Pacific Human Microbiome Market Outlook, By Nutritionally Incomplete Formulae (2013-2022) ($MN)
Table 93 Asia Pacific Human Microbiome Market Outlook, By Formulae for Metabolic Disorders (2013-2022) ($MN)
Table 94 Asia Pacific Human Microbiome Market Outlook, By Nutritionally Complete Formulae (2013-2022) ($MN)
Table 95 Asia Pacific Human Microbiome Market Outlook, By Oral Rehydration Products (2013-2022) ($MN)
Table 96 Asia Pacific Human Microbiome Market Outlook, By Other Probiotic Supplements (2013-2022) ($MN)
Table 97 RoW Human Microbiome Market Outlook, By Country (2013-2022) ($MN)
Table 98 RoW Human Microbiome Market Outlook, By Application (2013-2022) ($MN)
Table 99 RoW Human Microbiome Market Outlook, By Diagnostics (2013-2022) ($MN)
Table 100 RoW Human Microbiome Market Outlook, By Therapeutics (2013-2022) ($MN)
Table 101 RoW Human Microbiome Market Outlook, By Disease (2013-2022) ($MN)
Table 102 RoW Human Microbiome Market Outlook, By Cancer (2013-2022) ($MN)
Table 103 RoW Human Microbiome Market Outlook, By Acute Diarrhea (2013-2022) ($MN)
Table 104 RoW Human Microbiome Market Outlook, By Diabetes (2013-2022) ($MN)
Table 105 RoW Human Microbiome Market Outlook, By Mental Disorders (2013-2022) ($MN)
Table 106 RoW Human Microbiome Market Outlook, By Autoimmune Disorders (2013-2022) ($MN)
Table 107 RoW Human Microbiome Market Outlook, By Obesity (2013-2022) ($MN)
Table 108 RoW Human Microbiome Market Outlook, By Other Diseases (2013-2022) ($MN)
Table 109 RoW Human Microbiome Market Outlook, By Product (2013-2022) ($MN)
Table 110 RoW Human Microbiome Market Outlook, By Foods (2013-2022) ($MN)
Table 111 RoW Human Microbiome Market Outlook, By Drugs (2013-2022) ($MN)
Table 112 RoW Human Microbiome Market Outlook, By Probiotics (2013-2022) ($MN)
Table 113 RoW Human Microbiome Market Outlook, By Diagnostic Devices (2013-2022) ($MN)
Table 114 RoW Human Microbiome Market Outlook, By Prebiotics (2013-2022) ($MN)
Table 115 RoW Human Microbiome Market Outlook, By Medical Foods (2013-2022) ($MN)
Table 116 RoW Human Microbiome Market Outlook, By Nutritionally Incomplete Formulae (2013-2022) ($MN)
Table 117 RoW Human Microbiome Market Outlook, By Formulae for Metabolic Disorders (2013-2022) ($MN)
Table 118 RoW Human Microbiome Market Outlook, By Nutritionally Complete Formulae (2013-2022) ($MN)
Table 119 RoW Human Microbiome Market Outlook, By Oral Rehydration Products (2013-2022) ($MN)
Table 120 RoW Human Microbiome Market Outlook, By Other Probiotic Supplements (2013-2022) ($MN)

Human Microbiome - Global Market Outlook (2016-2022)

According to Stratistics MRC, the Global Human Microbiome Market is accounted for $130.23 million in 2015 and is expected to reach $521.23 million by 2022 growing at a CAGR of 21.9% during the forecast period. Increasing incidence of lifestyle diseases, growing geriatric population, and technological developments are some of the factors fueling the market growth. By product, Probiotics segment dominated the global market with largest share during the forecast period. North America and Europe commanded the market owing to the improved biotechnological and microbiological research infrastructure. However, Asia-Pacific is anticipated to grow at the highest CAGR owing to recuperating research infrastructure in the region.

Some of the key players in Human Microbiome market include Ritter Pharmaceuticals, Inc., E. I. du Pont de Nemours and Company, ViThera Pharmaceuticals, Metabiomics Corp., ActoGeniX, Optibiotix Health Plc, Vedanta Biosciences, Inc., MicroBiome Therapeutics, LLC, Second Genome, Inc., ENTEROME Bioscience, Yakult Honsha Co., Ltd., Osel, Inc., AvidBiotics, Rebiotix Inc., Merck & Co., Inc. and Seres Therapeutics.

Applications Covered:
Diagnostics
Therapeutics

Diseases Covered:
Cancer
Acute Diarrhea
Diabetes
Mental Disorders
Autoimmune Disorders
Obesity
Other Diseases

Products Covered:
Foods
Drugs
Probiotics
Diagnostic Devices
Prebiotics
Medical Foods
Nutritionally Incomplete Formulae
Formulae for Metabolic Disorders
Nutritionally Complete Formulae
Oral Rehydration Products
Other Probiotics Supplements

Regions Covered:
North America
US
Canada
Mexico
Europe
Germany
France
Italy
UK
Spain
Rest of Europe
Asia Pacific
Japan
China
India
Australia
New Zealand
Rest of Asia Pacific
Rest of the World
Middle East
Brazil
Argentina
South Africa
Egypt


What our report offers:
Market share assessments for the regional and country level segments
Market share analysis of the top industry players
Strategic recommendations for the new entrants
Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements


Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report

;